Intercept Pharm (ICPT) Earnings
|
Expand Research on ICPT
| Next EPS Date | N/A | EPS Growth Rate | +100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | -59.2% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | -3.0% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/6/23 | Q323 | N/A | -$0.25 | N/A | N/A | $88.5M | N/A | N/A | N/A | ||
| 11/1/23 | Q323 | N/A | -$0.25 | N/A | N/A | $88.5M | N/A | N/A | N/A | ||
| 8/2/23 | Q223 | -$0.14 | -$0.51 | +$0.37 | $83.72M | $79.57M | N/A |  | | Details | |
| 4/27/23 | Q123 | -$0.77 | -$0.63 | -$0.14 | $67.96M | $72.33M | N/A | | | Details | |
| 3/2/23 | Q422 | -$0.50 | -$0.43 | -$0.07 | $77.2M | $78.27M | N/A | | | Details | |
11/1/22  |
Q322 | -$3.04 | -$0.82 | -$2.22 | $77.6M | $73.74M | = | | | Details | |
| 11/1/22 | Q322 | -$0.11 | -$0.82 | +$0.71 | $92.83M | $73.74M | = | | | Details | |
| 8/3/22 | Q222 | -$0.25 | -$0.46 | +$0.21 | $71.76M | $95.98M | = | | | Details |
